rs1356154563
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_015474.4(SAMHD1):c.1293A>T(p.Leu431Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000559 in 1,611,320 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L431I) has been classified as Uncertain significance.
Frequency
Consequence
NM_015474.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SAMHD1 | NM_015474.4 | c.1293A>T | p.Leu431Phe | missense_variant | 12/16 | ENST00000646673.2 | |
SAMHD1 | NM_001363729.2 | c.1293A>T | p.Leu431Phe | missense_variant | 12/15 | ||
SAMHD1 | NM_001363733.2 | c.1293A>T | p.Leu431Phe | missense_variant | 12/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SAMHD1 | ENST00000646673.2 | c.1293A>T | p.Leu431Phe | missense_variant | 12/16 | NM_015474.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251284Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135850
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1459150Hom.: 0 Cov.: 29 AF XY: 0.00000275 AC XY: 2AN XY: 726096
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74352
ClinVar
Submissions by phenotype
Aicardi-Goutieres syndrome 5 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Apr 07, 2022 | This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 431 of the SAMHD1 protein (p.Leu431Phe). This variant is present in population databases (no rsID available, gnomAD 0.004%). This missense change has been observed in individual(s) with Aicardi-Goutieres syndrome (PMID: 30275001). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 559589). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | research | UNC Molecular Genetics Laboratory, University of North Carolina at Chapel Hill | Aug 06, 2018 | The SAMHD1 Leu431Phe (p.L431F) is an apparently novel missense variant that changes a single conserved amino acid from leucine to phenylalanine. Although this variant is not within either of the known functional protein domains, other nearby mutations have been associated with disease (Rice 2009, PMID: 19525956). This variant is absent from the ExAC database but observed in 1/24030 alleles in the GnomAD African population (allele frequency 0.00004). This variant has a score of 0.732 by the REVEL metapredictor (Ioannidis 2016, PMID: 27666373), which is below the ClinGen threshold cut-off (0.75) for application of ACMG/AMP in silico prediction evidence. This variant was observed in trans with a second missense variant (Ile201Asn), which is classified as likely pathogenic, in a patient with symptoms highly consistent with Aicardi-Goutieres syndrome. In summary, the Leu431Phe variant is currently considered a variant of uncertain significance based on ACMG/AMP criteria (PM2, PM3, PP4). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at